Monitoring GLP-1 RA prescription trends
Real-time monitoring of viral gastroenteritis: April 2024
New insights from family history can shed light on prostate cancer
Truveta Research and collaborators receive ISPOR 2024 Best General Poster Research Presentation award
Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism
Rod Hochman, MD, president and CEO of Providence, is new Truveta Board of Directors Chair
Real-world prescribing of lecanemab in the United States
Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions
